Should You Buy Tandem Diabetes Care Inc (TNDM) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Tandem Diabetes Care Inc (TNDM) is not a strong buy for a beginner investor with a long-term strategy at this time. While there are positive catalysts such as hedge fund buying and analyst optimism for 2026, the company's financial performance remains weak, with declining net income and EPS. Additionally, the ongoing legal investigation and potential securities fraud concerns present significant risks. The technical indicators and options data do not suggest a compelling entry point for the stock currently.
Technical Analysis
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is at 27.194, suggesting the stock is nearing oversold territory but not yet signaling a reversal. The stock is trading near its S1 support level of 19.829, with resistance at 22.499. Moving averages are converging, showing no clear trend.
Analyst Ratings and Price Target Trends
Analysts are cautiously optimistic, with multiple firms raising price targets to $25-$35. However, many maintain Neutral or Hold ratings, reflecting uncertainty about near-term performance despite a positive outlook for 2026.
Wall Street analysts forecast TNDM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNDM is 26.33 USD with a low forecast of 14 USD and a high forecast of 55 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast TNDM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNDM is 26.33 USD with a low forecast of 14 USD and a high forecast of 55 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 19.110
Current: 19.110
